Baseline | 6-months post-PEA | 1-year post-PEA | |
New York Heart Association functional class | |||
I | 0 | 16* | 17* |
II | 20 | 21* | 12* |
III | 22 | 2* | 1* |
Not applicable | 0 | 0 | 1 |
Haemodynamics | |||
Patients | 42 | 38# | |
Mean PAP mmHg | 21 (5) | 18 (5)* | |
Cardiac index L·min−1·m−2, | 2.6±0.5 | 2.5±0.4 | |
PVR dyn·s·cm−5 | 164 (104) | 128 (60)* | |
6-min walk test | |||
Patients | 37 | 34 | 27 |
Distance m | 372±117 | 413±90* | 421±113* |
Baseline SpO2 % | 97±2 | 97±2 | 97±2 |
Minimal SpO2 on exercise % | 91 (6) | 93 (5) | 93 (3)* |
CAMPHOR | |||
Patients | 36 | 31 | 27 |
Total score | 40 (33) | 11 (30)* | 11 (37)* |
Symptoms | 15 (13) | 4 (12)* | 5 (12)* |
Activity | 10 (9) | 5 (6)* | 4 (11)* |
Quality of life | 14 (14) | 2 (11)* | 1 (12)* |
Data are presented as n, median (interquartile range) or mean±sd. PAP: pulmonary arterial pressure; PVR: pulmonary vascular resistance; SpO2: peripheral oxygen saturation; CAMPHOR: Cambridge pulmonary hypertension outcome review. #: one patient refused to have a repeat right heart catheterisation at the 6-month post-surgical review. *: p<0.05 compared to baseline.